This Week on NeurologyLive


Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week.

Our Peer Exchange series, "Advances in the Management of Acute Treatment of Migraine," goes live this week, featuring insight from experts Peter J. Goadsby, MD, PhD; Dawn C. Buse, PhD; Wade M. Cooper, DO; Paul G. Mathew, MD; and Jelena Pavlovic, MD, PhD.

To check out the series, click here.

A conversation with James Leverenz, MD, director of the Cleveland Clinic Lou Ruvo Center for Brain Health at Cleveland Clinic, goes live this week. We sat down to discuss a multitude of topics within the Alzheimer disease arena, including the challenges of diagnosing the disease, new diagnostic tools, and research progression.

To check out our previous conversations with Leverenz, click here.

​Episode 19 of the "Mind Moments" podcast will go live this Friday, October 9, 2020. It features an interview with Costantino Iadecola, MD, director, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, who discusses the role of amyloid-beta in various types of Alzheimer disease and its impact on vascular dysfunction.

To subscribe on your favorite podcast player, click here.

In partnership with the Consortium of Multiple Sclerosis Centers (CMSC) and the International Organization for Multiple Sclerosis Nurses (IOMSN), the first of 2 upcoming webcast programs on multiple sclerosis (MS) taking place in October, “Differing Perspectives on Multiple Sclerosis Nursing Care” goes live on Saturday, October 10, 2020. It will air from 9:00 AM to 12:00 PM EDT, followed by a complimentary patient program from 12:30 PM to 2:30 PM EDT.

To register for the webinar, click here.

Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
Svetlana Blitshteyn, MD, FAAN, director and founder of Dysautonomia Clinic
© 2024 MJH Life Sciences

All rights reserved.